Signaling Pathways
-
A1835 Pelitinib (EKB-569)Summary: EGFR inhibitor,potent and irreversible
-
A2174 Lenvatinib (E7080)Target: VEGFR|PDGFR|RETSummary: VEGFR inhibitor
-
A1186 AMG-208Summary: C-Met inhibitor,potent and highly selective
-
A1393 WZ8040Target: EGFRSummary: EGFR T790M inhibitor,irreversible amd potent
-
A5057 MGCD-265Target: VEGFR|c-METSummary: Met/Flt/Flk/Ron/Tie-2 inhibitor
-
A5017 Motesanib Diphosphate (AMG-706)Summary: VEGFR/ PDGFR/c-Kit/Ret inhibitor
-
A2822 AC480 (BMS-599626)Target: EGFRSummary: HER1/2 inhibitor,selective and efficacious
-
A2974 Foretinib (GSK1363089)1 CitationSummary: VEGF and HGF receptor inhibitor
-
A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: Selective IGF-1R/IR inhibitor
-
A2278 NVP-AEW541Target: Insulin ReceptorSummary: IGF-IR inhibitor, novel, potent and selective